StockData
Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc. (AXSM) stock

AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/30
$134.00−1.95 (-1.43%)

Close on Nov 18, 2026Market cap $7.02BP/E –Yield –

Axsome Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Axsome Therapeutics's price to book ratio was 93.7× on Nov 11, 2026, against 103.4× a year earlier. Over the last 5 years it ranged from 10.4× to 230.6×, with a median of 68.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202693.7×−30.9
2025Dec 31, 2025124.6×+80.5
2024Dec 31, 202444.1×+30.1
2023Dec 29, 202314.0×−7.3
2022Dec 30, 202221.3×−12.0
2021Dec 31, 202133.3×+10.8
2020Dec 31, 202022.5×−176.6
2019Nov 29, 2019199.1×+98.6
2018Dec 31, 2018100.5×+92.6
2017Dec 29, 20177.9×+3.3
2016Dec 30, 20164.6×–

More Axsome Therapeutics figures

See a number that looks wrong?